CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer
Jae Yun Lim, Jang Ho Cho, Se Joon Lee, Dong Ki Lee, Dong Sup Yoon, Jae Yong Cho
Cancer Research and Treatment. 2015;47(2):266-273.   Published online 2014 August 29    DOI: https://doi.org/10.4143/crt.2013.158

Excel Download

Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer
Cancer Research and Treatment. 2014;47(2):266-273   Crossref logo
Link1 Link2 Link3

RM-028 Gemcitabine in combination with capecitabine compared with gemcitabine combined with erlotinib in locally advanced or metastatic pancreatic cancer
Annals of Oncology. 2016;27:ii92   Crossref logo
Link1 Link2 Link3

A Pilot Trial of Gemcitabine in Combination with Capecitabine or Erlotinib Compared to Gemcitabine alone in Patients with advanced Pancreatic Cancer
Annals of Oncology. 2012;23:ix240   Crossref logo
Link1 Link2

Phase I Trial of Gemcitabine Combined with Capecitabine and Erlotinib in Advanced Pancreatic Cancer: A Clinical and Pharmacological Study
Chemotherapy. 2012;58(5):371-380   Crossref logo
Link1 Link2

A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer
Lung Cancer. 2003;39(2):215-219   Crossref logo
Link1 Link2

Neoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable pancreatic adenocarcinoma
Cancer. 2014;121(5):673-680   Crossref logo
Link1 Link2

An International, Multicenter, Randomized Phase III Study of First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Versus First-Line Cisplatin/Gemcitabine Followed by Second-Line Erlotinib in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics of the TORCH Trial
Clinical Lung Cancer. 2008;9(4):235-238   Crossref logo
Link1 Link2

Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
Cancer Chemotherapy and Pharmacology. 2015;75(4):683-690   Crossref logo
Link1 Link2 Link3

Gemcitabine or capecitabine: does it matter which comes first in treating pancreatic cancer?
Community Oncology. 2010;7(8):382-383   Crossref logo
Link1 Link2

Gemcitabine plus capecitabine is effective in advanced pancreatic cancer
Nature Clinical Practice Oncology. 2007;4(9):504-504   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.